Home/Filings/4/0000899243-21-002770
4//SEC Filing

Katz Barrett 4

Accession 0000899243-21-002770

CIK 0001590750other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 7:33 PM ET

Size

9.6 KB

Accession

0000899243-21-002770

Insider Transaction Report

Form 4
Period: 2021-01-18
Katz Barrett
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-01-18+356,000356,000 total
    Exercise: $23.03Exp: 2031-01-17Common Stock (356,000 underlying)
Footnotes (1)
  • [F1]The option vests 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1
  • filerCIK 0001841628

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 7:33 PM ET
Size
9.6 KB